Stock Evaluator: Penumbra, Inc. (PEN)

Penumbra, Inc. PEN

$321.19 1.36 0.43%
July 31, 2026 4:00:02 PM EST November 10, 2021 Volume: 295,954
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Commentary & Analysis


Financial Summary

Share Statistics PEN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $12,651.5 $337.2 80%
Shares Out (Mil) 39.6 41.9 43%
Institutional Ownership 97.0% 77.8% 72%
Float (Mil) 38.2 34.7 41%
Beta 0.70 0.85 41%
Avg Daily Volume (000s) 423 278 56%
Price Change
(52-week)
26.4% 58.7% 66%
Growth PEN Industry
Median
Percentile
(All Stocks)
Sales (5yr) 20.2% 11.8% 82%
Net Income (5yr) 67.8% (5.8%) 97%
EPS (5yr) 65.1% 11.4% 97
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (108.3%) (16.3%) 1%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 11 4 13
Current EPS $1.182 $4.721 $6.232
Month Ago EPS $1.167 $4.860 $6.273
# Rev Up 1 1 0
# Rev Down 0 0 1
Three Months Ago EPS $1.188 $5.031 $6.378
Year/Year Chg 34.3% 4.4% 61.7%
Financials PEN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,505 $152 56%
Net Income (TTM) (Mil) $161 ($10) 66%
EPS (TTM) $4.094 ($0.500) 84%
Operating Cash Flow (TTM) (Mil) $278 ($2) 64%
Net Cash Flow (TTM) (Mil) ($217) $1 10%
Long-Term Debt (Q1) (Mil) $196 $22 50%
Enterprise Value (Q1) (Mil) $12,152 $304 77%
Valuation PEN Industry
Median
Percentile
(All Stocks)
P/B 8.27 2.80 87%
P/E 79.0 31.1 91%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.2 1.9 51%
Ratios PEN Industry
Median
Percentile
(All Stocks)
Gross Margin 67.8% 59.1% 79%
Net Margin 10.7% (7.3%) 65%
ROA 8.8% (13.7%) 85%
ROE 11.4% (15.8%) 62%
Liabilities to Assets 22.5% 44.7% 15%
F-Score 7 4 84%

Penumbra, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors